Steven Reynolds

Clinical Assistant Professor
MD, University of Calgary
Department of Medicine

Steve Reynolds graduated from the University of Calgary medical program in 2001, completed an Internal Medicine Residency at Dalhousie University, and completed fellowship training in Infectious Diseases and Critical Care at the University of British Columbia. He is the Site Medical Director of Royal Columbian Hospital, and previous Department Head and Regional Medical Director of Critical Care in Fraser Health. He practices critical care and has been heavily involved in providing direct care to COVID patients and helping to lead his hospital through the many challenges as one of the primary sites responsible for caring for critically ill patients with COVID. He recently stepped down as the chairperson of the FHA Heath Authority Medical Advisory Committee.

Steve holds the TB Vets Professorship in Critical Care in support of his research on negative pressure ventilation. He focuses on bench to bedside research and is the co-inventor of a medical device designed to assist breathing (www.lungpacer.com). His current projects involve physiological studies exploring the interaction of positive and negative pressure ventilation on lung injury, diaphragm injury and ventilator induced brain injury in a large animal model in a mock ICU. Other projects include studying the effects of a patient based, digital therapeutic device designed to calm patients with delirium without harmful medications, a multi-center clinical trial evaluating a novel antibiotic central line locking solution, and physiological studies of ventilation strategies employed in COVID patients.

Primary Recipient Awards

2020 Wall Scholars, Steven Reynolds, 2020

Steven Reynolds

As a Wall Scholar, Steve hopes to explore concepts around positive disruptive change in medicine. Specifically, strategies that will support sustainability of the system through reduction of interventions with marginal benefits and exploration of mechanisms to increase available resources in the system with no increased cost.